Cooper Financial Group

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1751581 IRVINE, CA

Position in VRTX

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$2,613,296

+$559,659 QoQ

Shares Held

5,261

+14.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

#606

of 1,735 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cooper Financial Group holds $3,046,656 across 2 Biotechnology names. VRTX ranks #1 (85.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	5,261	$2,613,296
2	REGN	Regeneron Pharmaceuticals, Inc.	695	$433,360

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,613,296	5,261	+14.4%	Shares	Sole	2026-07-08
2026-03-31	$2,053,637	4,599	-13.9%	Shares	Sole	2026-04-07
2025-12-31	$2,421,395	5,341	+130.2%	Shares	Sole	2026-01-08
2025-09-30	$908,604	2,320	-36.3%	Shares	Sole	2025-10-07
2025-06-30	$1,622,308	3,644	-21.4%	Shares	Sole	2025-07-18
2025-03-31	$2,248,110	4,637	-1.0%	Shares	Sole	2025-05-12
2024-12-31	$1,885,441	4,682	+16.1%	Shares	Sole	2025-01-13
2024-09-30	$1,874,737	4,031	+7.6%	Shares	Sole	2024-11-14
2024-06-30	$1,756,293	3,747	+3.3%	Shares	Sole	2024-07-15
2024-03-31	$1,516,122	3,627	+12.4%	Shares	Sole	2024-04-11
2023-12-31	$1,313,034	3,227	+6.9%	Shares	Sole	2024-01-16
2023-09-30	$1,050,174	3,020	+1.0%	Shares	Sole	2023-10-13
2023-06-30	$1,052,562	2,991	+11.0%	Shares	Sole	2023-07-07
2023-03-31	$848,798	2,694	+9.3%	Shares	Sole	2023-05-11
2022-12-31	$711,553	2,464	+23.3%	Shares	Sole	2023-01-13
2022-09-30	$578,500	1,998	+84.8%	Shares	Sole	2022-10-13
2022-06-30	$304,614	1,081	+15.4%	Shares	Sole	2022-07-11
2021-12-31	$205,765	937	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.